Before I forget, I distinctly recall Dr Maiti from MD Anderson in a zoom presentation saying that if we get a 20%+ improvement over standard of care in front line, we should qualify for a breakthrough designation from the FDA!!
I also distinctly recall Dr Maiti saying that MD Anderson were involved in 7 out of the last 10 FDA approved therapies for AML....so they will know exactly what GOOD LOOKS LIKE!
Ann: ADVENT-AML Phase 1B clinical trial update, page-20
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $6.045M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $22.28K | 6.311M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 78 | 84735861 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 86304338 | 23 |
View Market Depth
| Last trade - 14.27pm 25/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |